Literature DB >> 27031055

Foley Catheter or Oral Misoprostol for Induction of Labor in Women with Term Premature Rupture of Membranes: A Randomized Multicenter Trial.

Heidi Kruit1, Kati Tihtonen2, Tytti Raudaskoski3, Veli-Matti Ulander1, Ansa Aitokallio-Tallberg1, Oskari Heikinheimo1, Jorma Paavonen1, Leena Rahkonen1.   

Abstract

Objectives To compare the Foley catheter and misoprostol for induction of labor in term women with premature rupture of membranes. Study Design A randomized controlled trial was performed in three university hospitals in Finland between March 2012 and September 2014. A total of 202 term women with ruptured membranes >18 hours, singleton pregnancies in cephalic presentation, unfavorable cervix, and no prior cesarean section were enrolled. Participants were randomly allocated to induction of labor by Foley catheter or oral misoprostol in a 1:1 ratio. All women received prophylactic antibiotics. The main outcomes were cesarean section and maternal and neonatal infections. Results Labor induction by Foley catheter or misoprostol showed no difference in cesarean delivery rates (23.6 vs. 18.2%; odds ratio [OR], 1.39; 95% confidence interval [CI], 0.69-2.82; p = 0.36), maternal intrapartum infections (2.2 vs. 2%; OR, 1.12; 95% CI, 0.15-8.9; p = 1.00), postpartum infections (1.1 vs. 2.0%; OR, 0.55; 95% CI, 0.05-6.18; p = 1.00), or neonatal infections (1.1 vs. 5.1%; OR, 0.21; 95% CI, 0.24-1.87; p = 0.22). The total time from induction to delivery was similar (1,311 vs. 1,435 minutes; p = 0.31) in the two groups. Conclusions Foley catheter or misoprostol can both be used for induction of labor in women with term premature rupture of membranes. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27031055     DOI: 10.1055/s-0036-1580608

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  6 in total

1.  Induction of labor by Foley catheter compared with spontaneous onset of labor after previous cesarean section: a cohort study.

Authors:  H Kruit; H Wilkman; A Tekay; L Rahkonen
Journal:  J Perinatol       Date:  2017-04-13       Impact factor: 2.521

2.  Induction of labour in case of premature rupture of membranes at term with an unfavourable cervix: protocol for a randomised controlled trial comparing double balloon catheter (+oxytocin) and vaginal prostaglandin (RUBAPRO) treatments.

Authors:  Eric Devillard; Amélie Delabaere; Marion Rouzaire; Bruno Pereira; Marie Accoceberry; Céline Houlle; Lydie Dejou-Bouillet; Pamela Bouchet; Denis Gallot
Journal:  BMJ Open       Date:  2019-06-20       Impact factor: 2.692

3.  MEchanical DIlatation of the Cervix-- in a Scarred uterus (MEDICS): the study protocol of a randomised controlled trial comparing a single cervical catheter balloon and prostaglandin PGE2 for cervical ripening and labour induction following caesarean delivery.

Authors:  Soe-Na Choo; Abhiram Kanneganti; Muhammad Nur Dinie Bin Abdul Aziz; Leta Loh; Carol Hargreaves; Vikneswaran Gopal; Arijit Biswas; Yiong Huak Chan; Ida Suzani Ismail; Claudia Chi; Citra Mattar
Journal:  BMJ Open       Date:  2019-11-06       Impact factor: 2.692

Review 4.  Mechanical methods for induction of labour.

Authors:  Marieke Dt de Vaan; Mieke Lg Ten Eikelder; Marta Jozwiak; Kirsten R Palmer; Miranda Davies-Tuck; Kitty Wm Bloemenkamp; Ben Willem J Mol; Michel Boulvain
Journal:  Cochrane Database Syst Rev       Date:  2019-10-18

5.  Low-dose oral misoprostol for induction of labour.

Authors:  Robbie S Kerr; Nimisha Kumar; Myfanwy J Williams; Anna Cuthbert; Nasreen Aflaifel; David M Haas; Andrew D Weeks
Journal:  Cochrane Database Syst Rev       Date:  2021-06-22

6.  Double Balloon Catheter (Plus Oxytocin) versus Dinoprostone Vaginal Insert for Term Rupture of Membranes: A Randomized Controlled Trial (RUBAPRO).

Authors:  Eric Devillard; Fanny Petillon; Marion Rouzaire; Bruno Pereira; Marie Accoceberry; Céline Houlle; Lydie Dejou-Bouillet; Pamela Bouchet; Amélie Delabaere; Denis Gallot
Journal:  J Clin Med       Date:  2022-03-10       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.